Alzamend Neuro Inc. Stock
Price
Target price
€2.16
€2.16
-
-
-
-
09.02.24 / Frankfurt
WKN: A3EYCP / Name: Alzamend Neuro Inc. / Stock / ? /
We currently do not receive price updates for this security
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Financial data and news for Alzamend Neuro Inc.
sharewise wants to provide you with the best news and tools for Alzamend Neuro Inc., so we directly link to the best financial data sources.
Financials
News
![Alzamend Neuro Announces Reverse Stock Split: https://mms.businesswire.com/media/20240712249038/en/835633/5/Alzamend_Neuro_-_Corporate_Logo_with_R_mark_10262020.jpg.jpg](https://www.sharewise.com/rails/active_storage/representations/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBeDdUYkE9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--39fc016845ac6f2a226a3d0f4d690fb886dcd3d3/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdCam9MY21WemFYcGxTU0lKTXpVd2VBWTZCa1ZVIiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--aa36f503a05c343bf077379e5dc8bce118d9db18/Alzamend_Neuro_-_Corporate_Logo_with_R_mark_10262020.jpg?locale=us)
Alzamend Neuro Announces Reverse Stock Split
Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheim